Abstract
Amongst individuals with a mental health disorder, a comorbid diagnosis of cannabis use disorder (CUD) is associated with numerous adverse consequences, including more severe symptom profiles, poorer treatment response, and reduced psychosocial functioning. Contingency management (CM), a method to specifically reinforce target behavior attainment (e.g., substance use abstinence), may provide an effective intervention in treating cannabis use in patients with a dual diagnosis of CUD and a mental health disorder. A systematic search examining the effects of CM on cannabis use, clinical, cognitive, and psychosocial outcomes in patients with a mental health disorder on PubMed, PsycINFO, and EMBASE databases up to November 2022 was performed. Six studies met inclusion criteria for our review. We found CM to be efficacious in producing cannabis use reductions and abstinence amongst individuals with a psychotic-spectrum or major depressive disorder. Additional longitudinal studies with larger sample sizes, other psychiatric populations, and longer follow-up periods are needed to evaluate the sustained effects of CM.
Reference43 articles.
1. United Nations: Office on Drugs and Crime (2022, November 20). World Drug Report 2021. Available online: www.unodc.org/unodc/en/data-and-analysis/wdr2021.html.
2. Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012–2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III;Hasin;Am. J. Psychiatry,2016
3. Exploration of the Comorbidity of Cannabis Use Disorders and Mental Health Disorders among Inpatients Presenting to All Hospitals in New South Wales, Australia;Lai;Am. J. Drug Alcohol Abus.,2012
4. Hasin, D., and Walsh, C. (2020). Cannabis Use, Cannabis Use Disorder, and Comorbid Psychiatric Illness: A Narrative Review. J. Clin. Med., 10.
5. Cannabis Use and Cannabis Use Disorders among Individuals with Mental Illness;McKenzie;Compr. Psychiatry,2013
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献